Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL92768 | 1.00 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL215095 | 1.00 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL540415 | 1.00 | LMNA (0.41) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| Ammonia Solution, Strong SCHEMBL4744785 | 0.98 | LMNA (0.39) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL14808559 | 0.98 | LMNA (0.39) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| Ammonia Solution, Strong SCHEMBL2015573 | 0.98 | LMNA (0.39) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| Ammonia Solution, Strong SCHEMBL482689 | 0.98 | LMNA (0.39) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL7068618 | 0.94 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL7144047 | 0.94 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 | |
| SCHEMBL3864585 | 0.94 | LMNA (0.37) | LMNAL3MBTL1PDE4ATDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110408649-A | Application of the protein of NOR gene and its coding in regulation tamato fruit in flavonoids synthesis | UNIV CHINA AGRICULTURAL | 2019-11-05 | — | — | CN | claimed |
| CN-102180914-A | Preparation method of 2-deoxidizing-D-glucose | UNIV EAST CHINA NORMAL | 2011-09-14 | — | — | CN | claimed |
| EP-1606385-A4 | PLANT PRODUCTION OF IMMUNOGLOBULINS WITH REDUCED FUCOSYLATION | DOW CHEMICAL CO (US) | 2008-08-13 | — | — | EP | claimed |
| EP-1606385-A2 | PLANT PRODUCTION OF IMMUNOGLOBULINS WITH REDUCED FUCOSYLATION | THE DOW CHEMICAL COMPANY (US) | 2005-12-21 | — | — | EP | claimed |
| WO-2004050838-A2 | PLANT PRODUCTION OF IMMUNOGLOBULINS WITH REDUCED FUCOSYLATION | THE DOW CHEMICAL COMPANY (US) | 2004-06-17 | — | — | WO | claimed |
| CN-116656719-B | Application of fusarium graminearum FgPDA5 gene | 四川农业大学 | 2024-03-15 | — | — | CN | disclosed |
| CN-116656719-A | Application of fusarium graminearum FgPDA5 gene | 四川农业大学 | 2023-08-29 | — | — | CN | disclosed |
| US-20230227923-A1 | PHAGE-BASED DETECTION METHOD FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING AND IDENTIFICATION OF BACTERIAL SPECIES | ORTHO-CLINICAL DIAGNOSTICS, INC. | 2023-07-20 | — | — | US | disclosed |
| US-11560584-B2 | Phage-mediated immunoassay and methods for determining susceptibility of bacteria to antibiotic or probiotic agents | QUIDEL CORPORATION (US) | 2023-01-24 | — | — | US | disclosed |
| US-20210403995-A1 | HIGH-THROUGHPUT METHODS TO CHARACTERIZE PHAGE RECEPTORS AND RATIONAL FORMULATION OF PHAGE COCKTAILS | UNITED STATES DEPARTMENT OF ENERGY | 2021-12-30 | — | — | US | disclosed |
| CN-110408649-A | Application of the protein of NOR gene and its coding in regulation tamato fruit in flavonoids synthesis | UNIV CHINA AGRICULTURAL | 2019-11-05 | — | — | CN | disclosed |
| CN-110229802-A | Polypeptide with proteinase activity | 诺维信公司 | 2019-09-13 | — | — | CN | disclosed |
| EP-1606385-A4 | PLANT PRODUCTION OF IMMUNOGLOBULINS WITH REDUCED FUCOSYLATION | DOW CHEMICAL CO (US) | 2008-08-13 | — | — | EP | disclosed |
| EP-1648492-A4 | A NOVEL ANTIPROLIFERATIVE FACTOR AND METHODS OF USE | UNIV MARYLAND (US) | 2008-04-09 | — | — | EP | disclosed |
| EP-1648492-A2 | A NOVEL ANTIPROLIFERATIVE FACTOR AND METHODS OF USE | University of Maryland, Baltimore (US) | 2006-04-26 | — | — | EP | disclosed |
| EP-1606385-A2 | PLANT PRODUCTION OF IMMUNOGLOBULINS WITH REDUCED FUCOSYLATION | THE DOW CHEMICAL COMPANY (US) | 2005-12-21 | — | — | EP | disclosed |
| WO-2005016248-A2 | A NOVEL ANTIPROLIFERATIVE FACTOR AND METHODS OF USE | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2005-02-24 | — | — | WO | disclosed |
| WO-2004050838-A2 | PLANT PRODUCTION OF IMMUNOGLOBULINS WITH REDUCED FUCOSYLATION | THE DOW CHEMICAL COMPANY (US) | 2004-06-17 | — | — | WO | disclosed |
| WO-1995021618-A1 | IMMUNOMODULATION USING NKR-P1, CD69 AND LIGANDS THEREFOR | INSTITUTE OF MICROBIOLOGY (CZ) | 1995-08-17 | — | — | WO | disclosed |
| CN-85107911-A | The production method of ellipticine derivative | — | 1987-02-25 | — | — | CN | disclosed |